- •Uveitis
- •Foreword
- •Preface
- •Dedication
- •Acknowledgments
- •Elements of the Immune System and Concepts of Intraocular Inflammatory Disease Pathogenesis
- •Elements of the immune system
- •Macrophages/monocytes
- •Dendritic cells
- •T cells
- •Major subsets of T cells
- •Cytokines
- •T-cell subsets
- •T-regulatory cells
- •T-cell receptor
- •Chemokines
- •Thymic expression and central immune tolerance
- •B cells
- •Classes of Immunoglobulin
- •Other cells
- •Mast Cells
- •Eosinophils
- •Neutrophils
- •Resident Ocular Cells
- •Complement system
- •Cellular interactions: hypersensitivity reactions
- •Classic immune hypersensitivity reactions
- •Type I
- •Type II
- •Type III
- •Type IV
- •Type V
- •Concepts of disease pathogenesis
- •Immune characteristics of the eye
- •Absence of lymphatic drainage
- •Intraocular microenvironment
- •Anterior Chamber-Associated Immune Deviation (ACAID)
- •Fas-Fas Ligand Interactions and Programmed Cell Death (Apoptosis)
- •Resident Ocular Cells and Immune System
- •Cytokines and Chemokines and the Eye
- •Oral Tolerance
- •Choroidal circulation and anatomy
- •Retina
- •Immunogenetics
- •Class I antigens
- •Class II and class III antigens
- •Histocompatibility lymphocyte antigens
- •Single-nucleotide polymorphisms (SNPs)
- •Epigenetics
- •Immune complex-mediated disease
- •Gene expression profiling
- •Tissue damage in the eye
- •T-cell responses and autoimmunity
- •T-cell receptor and the expression of disease
- •Ocular autoimmunity
- •Uveitogenic antigens
- •Retinal S-Antigen (Arrestin)
- •Interphotoreceptor Retinoid-Binding Protein
- •Recoverin
- •Bovine Melanin Protein
- •Rhodopsin
- •Phosducin
- •Tyrosinase
- •Other Antigens
- •Endotoxin and Other Bacterial Antigens
- •Importance of Antigen Studies
- •Cell adhesion molecules and their role in lymphocyte homing and in disease
- •Immune responses to invading viruses and parasites
- •Suggested Readings
- •References
- •Medical History in the Patient with Uveitis
- •References
- •Sample Uveitis Questionnaire
- •FAMILY HISTORY
- •SOCIAL HISTORY
- •PERSONAL MEDICAL HISTORY
- •MEDICAL HISTORY
- •Examination of the Patient with Uveitis
- •Visual acuity
- •External examination
- •Pupils and extraocular muscles
- •Intraocular pressure measurement
- •Slit-lamp biomicroscopy
- •Conjunctiva
- •Cornea
- •Keratic Precipitates
- •Other Corneal Findings
- •Anterior chamber
- •Iris
- •Anterior chamber angle
- •Lens
- •Vitreous
- •Retina and choroid
- •Optic nerve
- •References
- •Development of a Differential Diagnosis
- •Forming a differential diagnosis
- •Classifying uveitis
- •Is the disease acute or chronic?
- •Is the inflammation granulomatous or nongranulomatous?
- •Is the disease unilateral or bilateral?
- •Where is the inflammation located in the eye?
- •What are the demographics of the patient?
- •What associated symptoms does the patient have?
- •What associated signs are present on physical examination?
- •What is the time course of the disease and response to previous therapy?
- •Case 4-1
- •Case 4-2
- •References
- •Diagnostic Testing
- •Pretest likelihood of disease
- •Receiver operating characteristic (ROC) curve
- •Diagnostic tests for uveitis
- •Laboratory tests
- •Image analysis
- •Skin testing
- •Tissue samples
- •Ancillary ophthalmic tests
- •Electrophysiology
- •Laser interferometry
- •Fluorescein angiography
- •Indocyanine green
- •Laser flare photometry
- •Optical coherence tomography
- •High-frequency ultrasound biomicroscopy and multifrequency ultrasound
- •Fundus autofluorescence
- •Other diagnostic tests
- •Polymerase chain reaction (PCR)
- •Rapid tests for herpes simplex and herpes zoster
- •Bone mineral density studies
- •Genetic testing for steroid-induced glaucoma
- •Neurologic tests
- •References
- •Evidence-Based Medicine in Uveitis
- •Study design
- •Clinical trials in uveitis
- •References
- •Philosophy, Goals, and Approaches to Medical Therapy
- •Goals and philosophy
- •Pain, photophobia, and discomfort
- •Degree and location of inflammatory disease
- •Evaluation of visual acuity and prospect of reversibility
- •Follow-up procedures and standardization of observations
- •General health and age of patient
- •Patient reliability, preferences, and understanding
- •Nonsurgical therapeutic options
- •Corticosteroids
- •Mode of Action
- •Preparations, Dosage Schedules, and Complications
- •Ozurdex.
- •Secondary Effects
- •Cytotoxic agents
- •Alkylating agents
- •Mode of Action
- •Indications and Dosages
- •Secondary Effects
- •Antimetabolites
- •Azathioprine
- •Mode of Action
- •Indications and Dosages
- •Secondary Effects
- •Mycophenolate mofetil
- •Methotrexate
- •Mode of Action
- •Indications and Dosages
- •Secondary Effects
- •Ciclosporin
- •Mode of Action
- •Dosages and Indications
- •Secondary Effects
- •Tacrolimus
- •Mode of Action
- •Indications and Dosages
- •Secondary Effects
- •Lx 211 (Voclosporin)
- •Rapamycin
- •Mode of Action
- •Indications and Dosages
- •Toxicity
- •Antibodies and monoclonal antibodies
- •Daclizumab
- •Etanercept
- •Infliximab (Remicade)
- •Adalimumab (Humira)
- •Efalizumab (Raptiva)
- •Rituximab (Rituxan)
- •Anakinra (Kineret)
- •Alemtuzumab (Campath-1H)
- •Abatacept (Orencia)
- •Intravenous immunoglobulin therapy
- •Oral tolerance
- •Interferon-α
- •Antiviral therapy
- •Aciclovir
- •Ganciclovir
- •Valaciclovir
- •Famciclovir
- •Foscarnet
- •Combined ganciclovir and foscarnet
- •Cidofovir
- •Fomivirsen
- •Colchicine
- •Mode of Action
- •Indications and Dosages
- •Secondary Effects
- •Mydriatic and cycloplegic agents
- •Antitoxoplasmosis therapy
- •Other therapeutic approaches
- •Immunostimulators
- •Plasmapheresis
- •Nonsteroidal antiinflammatory agents
- •References
- •Role of Surgery in the Patient with Uveitis
- •Considerations
- •Removal of band keratopathy
- •Corneal transplantation
- •Cataract surgery
- •Glaucoma surgery
- •Treatment of vitreoretinal disease
- •Laser treatment
- •Photodynamic therapy
- •Diagnostic surgery
- •Anterior chamber paracentesis
- •Chorioretinal biopsy
- •Subretinal surgery
- •Case 8-1
- •References
- •Bacterial and Fungal Diseases
- •Introduction
- •Leprosy
- •Clinical findings
- •Immunology and pathology
- •Therapy
- •Tuberculosis
- •Systemic disease
- •Ocular disease
- •Diagnosis
- •Therapy
- •Other bacterial infections
- •Brucellosis
- •Whipple’s disease
- •Treatment and prognosis
- •Chronic granulomatous disease
- •Fungal disease
- •Neuroretinitis
- •References
- •Spirochetal Diseases
- •Spirochetal infections and the eye
- •Spirochetes
- •Definition
- •Venereal treponemal diseases
- •Syphilis
- •Etiology and Epidemiology
- •Clinical Manifestations
- •Primary syphilis.
- •Secondary syphilis.
- •Latent syphilis.
- •Tertiary syphilis.
- •Benign tertiary syphilis.
- •Cardiovascular syphilis.
- •Neurosyphilis.
- •Congenital syphilis.
- •Ocular Manifestations
- •Diagnosis
- •Prognosis
- •Treatment
- •General recommendations.
- •Approach to Syphilis in Patients with AIDS
- •Nonvenereal treponematoses
- •Endemic syphilis
- •Etiology and Epidemiology
- •Clinical Manifestations
- •Ocular Manifestations
- •Diagnosis
- •Prognosis
- •Treatment
- •Yaws and pinta
- •Ocular Manifestations
- •Diagnosis
- •Prognosis
- •Treatment
- •Borrelia infection
- •Lyme disease
- •Etiology and Epidemiology
- •Clinical Manifestations
- •Ocular Manifestations
- •Diagnosis
- •Prognosis
- •Treatment
- •Relapsing fever
- •Etiology and Epidemiology
- •Clinical Manifestations
- •Ocular Manifestations
- •Diagnosis
- •Prognosis
- •Treatment
- •Leptospirosis
- •Etiology and Epidemiology
- •Clinical Manifestations
- •Ocular Manifestations
- •Weil’s disease
- •Diagnosis
- •Prognosis
- •Treatment
- •Case 10-1
- •References
- •Acquired Immunodeficiency Syndrome
- •Human immunodeficiency virus
- •Epidemiology
- •Diagnosis
- •HIV disease
- •HIV therapy
- •Ocular manifestations of HIV infection
- •Ocular infection
- •Cytomegalovirus retinitis
- •Progression
- •CMV retinitis in the era of highly active antiretroviral therapy
- •Treatment
- •Intravitreal ganciclovir implant
- •Current therapeutic approach to CMV retinitis in the era of HAART
- •Retinal detachment
- •Prognosis
- •Immune recovery uveitis
- •Herpes zoster
- •Pneumocystis jirovecii choroiditis
- •Mycobacterium avium-intracellulare choroiditis
- •Other diseases
- •Drug-related ocular inflammation
- •Case 11-1
- •Case 11-2
- •References
- •Acute retinal necrosis
- •Epidemiology
- •Clinical features
- •Etiology
- •Differential diagnosis
- •Therapy
- •Progressive outer retinal necrosis
- •Diagnosis
- •Differential diagnosis
- •Etiology
- •Therapy
- •Case 12-1
- •Case 12-2
- •References
- •Other Viral Diseases
- •Herpes simplex virus kerititis and keratouveitis
- •Pathogenesis
- •Diagnosis
- •Treatment
- •Herpes zoster ophthalmicus
- •Treatment
- •West Nile virus
- •Epidemiology
- •Diagnosis
- •Clinical description
- •Ophthalmic manifestations
- •Treatment
- •Prognosis
- •Other viral infections
- •Human T-lymphotropic virus type I
- •Case 13-1
- •References
- •Ocular Toxoplasmosis
- •Organism
- •Clinical manifestations
- •Systemic
- •Ocular
- •Decreased Vision
- •Loss of Vision
- •Effects in immunocompromised host
- •Histopathology and immune factors
- •Immune response
- •Inflammatory response
- •Methods of diagnosis
- •Pregnancy
- •Other methods
- •Congenital versus acquired disease
- •Therapy
- •Additional therapeutic approaches
- •Case 14-1
- •Case 14-2
- •Case 14-3
- •Case 14-4
- •References
- •Ocular Histoplasmosis
- •Systemic findings
- •Ocular appearance
- •‘Histo’ spots
- •Maculopathy
- •Peripapillary pigment changes
- •Clear vitreous
- •Etiology and immunology
- •Nonsurgical therapies
- •Laser therapy
- •Subretinal surgery
- •References
- •Toxocara canis
- •Ocular manifestations
- •Histopathology and immune factors
- •Enzyme-linked immunoabsorbent assay
- •Treatment
- •Case 16-1
- •References
- •Onchocerciasis and Other Parasitic Diseases
- •Onchocerciasis
- •Clinical appearance
- •Immune characteristics
- •Therapy
- •Giardiasis
- •Ophthalmomyiasis
- •Cysticercosis
- •Caterpillar hairs
- •Amebiasis
- •Diffuse unilateral subacute neuroretinitis (DUSN)
- •Malaria
- •Seasonal hyperacute panuveitis (SHAPU)
- •References
- •Postsurgical Uveitis
- •Acute bacterial endophthalmitis
- •Chronic bacterial endophthalmitis
- •Fungal endophthalmitis
- •Endogenous endophthalmitis
- •Lens-induced uveitis
- •Toxic anterior segment syndrome (TASS)
- •Laser-induced uveitis
- •Case 18-1
- •References
- •Anterior Uveitis
- •Epidemiology
- •Clinical description
- •Idiopathic anterior uveitis
- •Diagnostic workup
- •Treatment
- •HLA-B27–associated anterior uveitis
- •Epidemiology
- •Demographics and clinical findings
- •Etiology
- •HLA-B27–associated anterior uveitis with systemic disease
- •Ankylosing spondylitis
- •Etiology
- •Treatment
- •Reactive arthritis (Reiter’s syndrome)
- •Juvenile idiopathic arthritis
- •Diagnosis
- •Pathology
- •Differential diagnosis
- •Treatment and prognosis
- •Psoriatic arthropathy
- •Inflammatory bowel disease
- •Whipple’s disease
- •Disease associations
- •Fuchs’ heterochromic iridocyclitis
- •Etiology
- •Treatment and prognosis
- •Kawasaki disease
- •Tubulointerstitial nephritis and uveitis syndrome (TINU)
- •Pathogenesis
- •Glaucomatous cyclitic crisis
- •Schwartz syndrome
- •Anterior segment ischemia
- •Lens-induced uveitis
- •Anterior uveitis associated with AIDS
- •Other disease associations
- •References
- •Scleritis
- •Episcleritis
- •Scleritis
- •Disease associations
- •Other causes of scleritis
- •Diagnostic testing
- •Pathogenesis
- •Differential diagnosis
- •Treatment
- •References
- •Intermediate Uveitis
- •Epidemiology
- •Clinical manifestations
- •Prognosis
- •Differential diagnosis
- •Multiple sclerosis
- •Etiology
- •Treatment
- •Corticosteroids
- •Immunosuppressive agents
- •Surgery
- •Case 21-1
- •Case 21-2
- •References
- •Sarcoidosis
- •Epidemiology
- •Etiology
- •Clinical manifestations
- •Anterior uveitis
- •Posterior segment findings
- •Systemic involvement
- •Pathology
- •Diagnosis
- •Treatment
- •Case 22-1
- •References
- •Sympathetic Ophthalmia
- •Clinical appearance and prevalence
- •Classic presentation
- •Sequelae
- •Tests and immunologic characteristics
- •Dalen–fuchs nodules
- •Preservation of the choriocapillaris
- •Therapy
- •Corticosteroids
- •Immunosuppressive agents
- •Case 23-1
- •Case 23-2
- •References
- •Vogt–Koyanagi–Harada Syndrome
- •Clinical aspects
- •Systemic findings
- •Ocular findings
- •Course of disease
- •Laboratory tests, etiology, and histopathology
- •Antigen-specific and immune responses
- •Vogt–Koyanagi–Harada syndrome versus sympathetic ophthalmia
- •Therapy
- •Cataract extraction
- •Case 24-1
- •Case 24-2
- •References
- •Birdshot Retinochoroidopathy
- •Clinical manifestations
- •Ocular examination and ancillary clinical tests
- •Tests, histology and etiology
- •Therapy
- •Case 25-1
- •Case 25-2
- •References
- •Behçet’s Disease
- •Clinical manifestations
- •Oral aphthous ulcers
- •Skin lesions
- •Genital ulcers
- •Ocular disease
- •Retinal disease
- •Complications
- •Minor criteria
- •Arthritis
- •Vascular alterations
- •Neurologic involvement (neuro-Behçet’s disease)
- •Immunologic and histologic considerations
- •Role of T cells (but other cells count too!)
- •HLA typing and single nucleotide polymorphisms (SNPs)
- •Therapy
- •Systemic corticosteroids
- •Cytotoxic and antimetabolic agents
- •Colchicine
- •Interferon-α
- •Ciclosporin and tacrolimus (FK506)
- •Anti-TNF therapy (infliximab)
- •Other approaches
- •Case 26-1
- •Case 26-2
- •Case 26-3
- •References
- •Retinal Vasculitis
- •Clinical characteristics
- •Ocular vasculitic disorders without systemic disease
- •Eales’ disease
- •Idiopathic retinal vasculitis, aneurysms, and neuroretinitis (IRVAN syndrome)
- •Frosted branch angiitis
- •Scleritis
- •Ocular vasculitic disorders with systemic disease
- •Systemic lupus erythematosus
- •Polyarteritis nodosa
- •Wegener’s granulomatosis
- •Whipple’s disease
- •Inflammatory bowel disease
- •Autoantibodies to Sjögren’s syndrome A antigen
- •Retinal vein occlusion
- •Relapsing polychondritis
- •Viral diseases
- •Multiple sclerosis
- •Tuberculosis
- •Rheumatoid arthritis
- •Kikuchi–Fujimoto disease
- •Susac syndrome
- •Sweet syndrome
- •References
- •Serpiginous Choroidopathy
- •Clinical features
- •Pathology
- •Etiology
- •Differential diagnosis
- •Therapy
- •Case 28-1
- •Case 28-2
- •Case 28-3
- •References
- •White-Dot Syndromes
- •Multiple evanescent white-dot syndrome
- •Clinical findings
- •Laboratory findings
- •Therapy
- •Multifocal choroiditis and panuveitis
- •Clinical findings
- •Punctate inner choroidopathy
- •Laboratory findings
- •Therapy
- •Acute retinal pigment epitheliitis
- •Clinical findings
- •Laboratory findings
- •Therapy
- •Acute posterior multifocal placoid pigment epitheliopathy
- •Clinical findings
- •Etiology
- •Therapy
- •Subretinal fibrosis and uveitis syndrome
- •Clinical findings
- •Laboratory findings
- •Therapy
- •Acute zonal occult outer retinopathy (AZOOR) and the azoor complex diseases
- •Case 29-1
- •Case 29-2
- •Case 29-3
- •References
- •Masquerade Syndromes
- •Intraocular lymphoma
- •Non-Hodgkin’s lymphoma of central nervous system
- •Diagnosis
- •Treatment
- •Systemic Non-Hodgkin’s lymphoma metastatic to eye
- •Lymphoid hyperplasia of uvea
- •Other malignant processes manifesting as uveitis
- •Paraneoplastic syndromes
- •Multiple sclerosis
- •Other nonmalignant conditions
- •References
- •Introduction
- •Age-related macular degeneration
- •Animal work
- •Animal laser model
- •Ccl2 and Ccr2 knockout model
- •Ccl2 and Cx3cr1 double knockout model
- •CEP induced AMD-like disease
- •Human data
- •Autoimmunity
- •Gene associations
- •Macrophages and other cells
- •Histopathology
- •The downregulatory immune environment
- •Should we consider immunotherapy?
- •Diabetic retinopathy
- •Diabetes and the immune process
- •Animal work
- •Human observations
- •Can we begin to think about immune therapy for diabetes and diabetic retinopathy?
- •Glaucoma
- •Autoantibodies and glaucoma
- •Cellular immunity and glaucoma
- •Can immune intervention help alter the course of glaucoma?
- •References
- •Index
Part 2 • Diagnosis
|
|
|
Development of a Differential Diagnosis |
|
Chapter |
4 |
|||
|
|
|
||
|
|
Table 4-4 Systemic signs and symptoms in uveitis |
||
|
|
Symptom or Sign |
Possible Associated Conditions |
|
|
|
Headaches |
Sarcoidosis, Vogt–Koyanagi–Harada |
|
|
|
|
|
syndrome |
|
|
|
|
|
|
|
Neurosensory deafness |
Vogt–Koyanagi–Harada syndrome, sarcoidosis |
|
|
|
|
|
|
|
|
Cerebrospinal fluid |
Vogt–Koyanagi–Harada syndrome, |
|
|
|
pleocytosis |
sarcoidosis, acute posterior multifocal placoid |
|
|
|
|
|
pigment epitheliopathy, Behçet’s syndrome |
|
|
|
|
|
|
|
Paresthesia, weakness |
Intermediate uveitis associated with multiple |
|
|
|
|
|
sclerosis, Behçet’s syndrome, steroid |
|
|
|
|
myopathy |
|
|
|
|
|
|
|
Psychosis |
Vogt–Koyanagi–Harada syndrome, |
|
|
|
|
|
sarcoidosis, Behçet’s disease, steroid |
|
|
|
|
psychosis, systemic lupus erythematosus |
|
|
|
|
|
|
|
Vitiligo, poliosis |
Vogt–Koyanagi–Harada syndrome |
|
|
|
|
|
|
|
|
Erythema nodosum |
Behçet’s syndrome, sarcoidosis |
|
|
|
|
|
|
|
|
Skin nodules |
Sarcoidosis, onchocerciasis |
|
|
|
|
|
|
|
|
Alopecia |
Vogt–Koyanagi–Harada syndrome |
|
|
|
|
|
|
|
|
Skin rash |
Behçet’s syndrome, sarcoidosis, viral |
|
|
|
|
|
exanthem, syphilis, herpes zoster, psoriatic |
|
|
|
|
arthritis, Lyme disease |
|
|
|
|
|
|
|
Oral ulcers |
Behçet’s syndrome, inflammatory bowel |
|
|
|
|
|
disease |
|
|
|
|
|
|
|
Genital ulcers |
Behçet’s syndrome, Reiter’s syndrome, |
|
|
|
|
|
sexually transmitted diseases |
|
|
|
|
|
|
|
Salivary or lacrimal |
Sarcoidosis, lymphoma |
|
|
|
gland swelling |
|
|
|
|
|
|
|
|
|
Lymphoid organ |
Sarcoidosis, AIDS |
|
|
|
enlargement |
|
|
|
|
|
|
|
|
|
Diarrhea |
Whipple’s disease, inflammatory bowel |
|
|
|
|
|
disease |
|
|
|
|
|
|
|
Cough, shortness of |
Sarcoidosis, tuberculosis, malignancy |
|
|
|
breath |
|
|
|
|
|
|
|
|
|
Sinusitis |
Wegener’s granulomatosis |
|
|
|
|
|
|
|
|
Systemic vasculitis |
Behçet’s syndrome, sarcoidosis, relapsing |
|
|
|
|
|
polychondritis |
|
|
|
|
|
|
|
Arthritis |
Behçet’s syndrome, Reiter’s syndrome, |
|
|
|
|
|
sarcoidosis, juvenile rheumatoid arthritis, |
|
|
|
|
rheumatoid arthritis, Lyme disease, |
|
|
|
|
inflammatory bowel disease, Wegener’s |
|
|
|
|
granulomatosus, systemic lupus |
|
|
|
|
erythematosus, other connective tissue |
|
|
|
|
diseases |
|
|
|
|
|
|
|
Sacroiliitis |
Ankylosing spondylitis, Reiter’s syndrome, |
|
|
|
|
|
inflammatory bowel disease |
|
|
|
|
|
|
|
Chemotherapy or other |
Cytomegalovirus retinitis, Candida retinitis, |
|
|
|
immunosuppression |
other opportunistic organisms |
|
|
|
|
|
|
Once the above questions are answered, lists of possible diagnoses are generated. By determining the diagnoses that appear most frequently, a final list of the most likely conditions responsible for the patient’s uveitis is generated. The clinician can then order diagnostic studies to discern among them. The following cases will help to illustrate the process of developing a differential diagnosis in the patient with uveitis.
Table 4-5 Common causes of anterior and posterior uveitis
|
Perkins |
Henderly |
|
et al. |
et al. |
Diagnosis |
(%)* |
(%)† |
ANTERIOR UVEITIS |
|
|
|
|
|
Idiopathic anterior uveitis |
32.7 |
12.1 |
|
|
|
HLA-B27-associated anterior uveitis |
– |
3.0 |
|
|
|
Juvenile rheumatoid arthritis |
5.1 |
2.8 |
|
|
|
Fuchs’ heterochromic iridocyclitis |
6.3 |
1.8 |
|
|
|
Ankylosing spondylitis |
5.7 |
1.5 |
|
|
|
Reiter’s syndrome |
5.2 |
1.0 |
|
|
|
Inflammatory bowel disease |
2.9 |
0.3 |
|
|
|
Syphilis |
1.2 |
0.8 |
|
|
|
Intraocular lens-related anterior uveitis |
– |
1.0 |
POSTERIOR UVEITIS |
|
|
|
|
|
Toxoplasmic retinochoroiditis |
9.2 |
7.0 |
|
|
|
Idiopathic retinal vasculitis |
4.6 |
6.8 |
|
|
|
Idiopathic posterior uveitis |
6.9 |
3.7 |
|
|
|
Ocular histoplasmosis |
– |
3.5 |
|
|
|
Toxocariasis |
2.9 |
2.6 |
|
|
|
Serpiginous choroidopathy |
– |
2.0 |
|
|
|
Acute posterior multifocal placoid pigment |
– |
1.8 |
epitheliopathy |
|
|
|
|
|
Acute retinal necrosis |
– |
1.3 |
|
|
|
Birdshot choroidopathy |
– |
1.2 |
|
|
|
Intraocular lymphoma |
1.1 |
1.2 |
|
|
|
*Data from Perkins ES, Folk J. Uveitis in London and Iowa. Ophthalmologica 1984; 36: 189.
†Data from Henderly DE, Genstler AJ, Smith RE, et al. Changing patterns of uveitis. Am J Ophthalmol 1987; 103: 131–6.
Case 4-1
A 42-year-old white woman presented with a 10-year history of bilateral uveitis treated intermittently with topical and systemic corticosteroids and a chief complaint of blurred vision that was worse in the left eye. A detailed medical history was significant for sinusitis and depression. On examination, her visual acuity was 20/50 in the right eye and 20/100 in the left. Slit-lamp biomicroscopy showed mutton-fat KPs in the left eye. There were trace vitreous cells and haze in the right eye and 2+ vitreous cells and haze in the left eye. There were peripheral retinal vasculitis and cystoid macular edema in both eyes (Fig. 4-1). Physical examination revealed no rash, joint findings, or other abnormalities. Neurologic examination was normal.
Most clinicians will find it difficult to derive an erudite differential diagnosis from simply reading this case history, but by classifying the uveitis with the eight questions previously outlined, lists of possible diagnoses can be generated. By comparing these lists, the most likely diagnoses can then be identified. Question 1 asks whether the disease is acute or
56
Figure 4-1. Late phase of fluorescein angiogram showing staining of blood vessel walls and leakage of dye from peripheral retinal vasculature.
chronic. Because the patient has a 10-year history of disease, the uveitis is clearly chronic and this is associated with the diseases listed in Box 4-2. The patient has mutton-fat KPs, suggesting that the uveitis is granulomatous, and this suggests the list of diagnoses shown in Box 4-3. The disease is bilateral, which does not point to a specific set of diseases; however, with prominent vitritis and peripheral retinal vasculitis, the anatomic classification of an intermediate uveitis does suggest a specific set of possible diseases to the clinician (Box 4-6). The patient is white and in the 24–45-year age range, suggesting the diagnoses shown in Table 4-2. As seen in Table 4-4, a complaint of sinusitis suggests a possible diagnosis of Wegener’s granulomatosis, but the patient had no specific findings on physical examination.
In summary, the uveitis can be classified as a chronic, granulomatous, bilateral, intermediate uveitis in a middle-aged white woman with intermittent response to topical and systemic corticosteroids. The lists containing possible diagnoses for this patient are shown in Box 4-9. If you compare these lists, the most frequently mentioned disorders include sarcoidosis, other causes of intermediate uveitis such as multiple sclerosis and inflammatory bowel disease, and other chronic disorders such as Behçet’s disease and Wegener’s granulomatosis. Diagnostic tests were then ordered to discern between the most likely disorders. Results of a diagnostic evaluation for sarcoidosis and Wegener’s granulomatosis, including a chest X-ray, serum angiotensin-converting enzyme level, antineutrophil cytoplasmic antibody test, and CT scan of the sinuses, were normal. However, an MRI scan of the brain revealed lesions consistent with a diagnosis of multiple sclerosis. The patient later developed an episode of lower extremity weakness followed by a second episode of paresthesia that extended to the level of the umbilicus that was diagnostic of this disease.
Case 4-2
A 73-year-old white woman presented with blurred vision in both eyes that had been present during the previous year. The patient first noted floaters in the left eye 1 year ago, but did not see an ophthalmologist until 3 months earlier, when she was
Classifying uveitis
Box 4-9 Lists of diagnoses generated for Case 4-1
Chronic, granulomatous, bilateral, intermediate uveitis in a middle-aged white woman with intermittent response to topical and systemic corticosteroids
CHRONIC UVEITIS
Juvenile rheumatoid arthritis Birdshot choroidopathy Serpiginous choroidopathy Tuberculous uveitis
Postsurgical uveitis (Propionibacterium acnes, fungal) Intraocular lymphoma
Sympathetic ophthalmia Multifocal choroiditis Sarcoidosis
Intermediate uveitis/pars planitis INTERMEDIATE UVEITIS Sarcoidosis
Inflammatory bowel disease Multiple sclerosis
Lyme disease Pars planitis
GRANULOMATOUS INFLAMMATION IN EYE Sarcoidosis
Sympathetic ophthalmia
Uveitis associated with multiple sclerosis Lens-induced uveitis
Intraocular foreign body Vogt–Koyanagi–Harada syndrome Syphilis
Tuberculosis
Other infectious agents AGE 25–45 YR Ankylosing spondylitis Idiopathic anterior uveitis
Fuchs’ heterochromic iridocyclitis Intermediate uveitis Toxoplasmosis
Behçet’s disease Idiopathic retinal vasculitis Sarcoidosis
White-dot syndromes Vogt–Koyanagi–Harada syndrome AIDS
Syphilis
Serpiginous choroidopathy ASSOCIATED SYMPTOMS AND SIGNS Sinusitis – Wegener’s disease
found to have a slight decrease in visual acuity in the left eye and bilateral mild vitritis. Over the next 3 months her vision decreased in both eyes, and she was referred to the National Eye Institute. She had a history of type II diabetes mellitus controlled with oral hypoglycemic agents, and of rheumatic fever as a child. She also complained of weight loss and unsteady gait. She lived in a wooded area in Glen Falls, New York.
On examination, visual acuity was 20/50 in the right eye and 20/125 in the left. Anterior segment examination was normal, but there were 2+ vitreous cells and 1+ vitreous haze in both
57
Part 2 • Diagnosis
Chapter 4 Development of a Differential Diagnosis
Figure 4-2. Fundus photograph showing yellow subretinal infiltrates, retinal hemorrhage, and retinal edema in eye with 20/125 visual acuity and moderate vitritis.
eyes. Funduscopic examination revealed punctate yellow subretinal infiltrates in both eyes and retinal hemorrhage and edema in the left eye (Fig. 4-2). Physical examination revealed ataxia.
Again, this patient’s condition presents difficulty in diagnosis, but with the approach detailed in Case 4-1 a differential diagnosis can be readily developed. The disease is chronic and the inflammation nongranulomatous. It is a bilateral disease and is classified as a multifocal retinitis. Therefore the patient is classified as having a chronic, nongranulomatous, bilateral, multifocal retinitis. She is an elderly white woman, and the history of living in a wooded area suggests a demographic susceptibility to Lyme disease. Her symptom of weight loss suggests the possibility of an underlying malignancy, malnutrition, or possible gastrointestinal disease, and the unsteady gait alerts the clinician to the possibility of neurologic disease. The diagnoses generated by this classification are shown in Box 4-10. As you can see, the most frequently listed diagnoses include sarcoidosis, infectious diseases, and the masquerade syndromes, most notably intraocular lymphoma.
Our first concern was that the patient had an underlying malignancy. Systemic evaluation was unrewarding, and a vitrectomy showed no malignant cells. However, two measurements of serum angiotensin-converting enzyme levels were elevated at 81 U/L and 101 U/L (normal range 8–52 U/L), and a bronchoscopy confirmed the diagnosis of sarcoidosis.
We hope that this chapter will provide the clinician with a pragmatic approach to generating a differential diagnosis. This
Box 4-10 Lists of diagnoses generated for Case 4-2
Chronic, nongranulomatous, bilateral, multifocal retinitis in an elderly white woman
CHRONIC UVEITIS
Juvenile rheumatoid arthritis Birdshot choroidopathy Serpiginous choroidopathy Tuberculous uveitis
Postsurgical uveitis (Propionibacterium acnes, fungal) Intraocular lymphoma
Sympathetic ophthalmia Multifocal choroiditis Sarcoidosis
Intermediate uveitis/pars planitis GRANULOMATOUS INFLAMMATION IN THE EYE Sarcoidosis
Sympathetic ophthalmia
Uveitis associated with multiple sclerosis Lens-induced uveitis
Intraocular foreign body Vogt–Koyanagi–Harada syndrome Syphilis
Tuberculosis
Other infectious agents MULTIFOCAL RETINITIS Syphilis
Herpes simplex virus Cytomegalovirus Sarcoidosis Masquerade syndromes
Candida
Meningococcus AGE >65 YR
Idiopathic anterior uveitis Idiopathic intermediate uveitis Idiopathic retinal vasculitis Serpiginous choroidopathy Masquerade syndromes Sarcoidosis
DEMOGRAPHIC CONSIDERATIONS
Patient lives in an area endemic for Lyme disease
will then permit the ophthalmologist to order the appropriate tests to discern among the most likely possibilities. As you will see in Chapter 5, the alternative shotgun approach of indiscriminately ordering every diagnostic test in the book may be both expensive and misleading.
References
1.de Groot AD. Thought and choice in chess. The Hague: Mouton Publishers 1965.
2.de Groot AD, Gobet F. Perception and memory in chess. Studies
in the heuristics of the
professional eye. Assen: Van Gorcum, 1966.
3.Jabs DA, Nussenblatt RB, Rosenbaum JT. Standardization of Uveitis Nomenclature (SUN) Working Group. Standardization of uveitis nomenclature for reporting clinical data. Results of the First International Workshop. Am J Ophthlamol 2005; 140: 509–516.
4.Bloch-Michel E, Nussenblatt RB. International Uveitis Study Group recommendations for the evaluation of intraocular inflammatory disease. Am J Ophthalmol 1987; 103: 234–235.
58
- #28.03.202681.2 Mб0Ultrasonography of the Eye and Orbit 2nd edition_Coleman, Silverman, Lizzi_2006.pdb
- #
- #
- #
- #28.03.202621.35 Mб0Uveitis Fundamentals and Clinical Practice 4th edition_Nussenblatt, Whitcup_2010.chm
- #
- #
- #28.03.202627.87 Mб0Vaughan & Asbury's General Ophthalmology 17th edition_Riordan-Eva, Whitcher_2007.chm
- #
- #
- #
